Press-release for stocks related to trial

Prices are updated after-hours

FSD Pharma submitted a Clinical Trial Application for a planed Phase-1 clinical trial for LUCID-MS
Published: 2023-01-20 (Crawled : 11:00) - fsdpharma.com
HUGE | News | $0.469 -4.09% -4.26% 110K

| -47.94% | O: 0.0% H: 3.15% C: -1.59%
pharma lucid-ms application trial phase 1

| -59.03% | O: 1.64% H: 6.45% C: 6.45%
clearance pharma drug candidate trial sclerosis lucid-ms lucid-21-302 phase 1

Video: FSD Pharma submitted a Clinical Trial Application for a planed Phase-1 clinical trial for LUCID-MS
Published: 2023-01-20 (Crawled : 07:00) - fsdpharma.com
HUGE | News | $0.469 -4.09% -4.26% 110K

| -47.94% | O: 0.0% H: 3.15% C: -1.59%
pharma application trial lucid-ms phase 1

| -46.66% | O: 4.59% H: 0.0% C: -2.55%
pharma application trial lucid-ms lucid-21-302 phase 1

| -50.51% | O: -1.09% H: 1.1% C: -1.92%
fsd-201 fda pharma drug canada health application trial phase 2

78%

22%

MTTR | News 4 | $4.6 164.37% 62.17% 28M

AGBA | $2.94 135.2% 57.48% 66M

EDBL | News | $6.46 71.81% 41.8% 2M

MTC | $2.25 44.23% 30.67% 6M

OPRT | News | $3.175 41.11% 29.13% 12M

SHIM | $3.05 35.56% 26.23% 1.1M

HKIT | $1.345 31.86% 24.16% 390K

ABVC | $1.36 30.77% 23.53% 7.4M

OST | $0.512 28.0% 21.88% 290K

POET | $1.59 27.2% 21.38% 4.2M

Save your searches and get alerts when important news are released.